Clinical Trial
Accepted on 08 Oct 2025
Safety, Tolerability, and Immunogenicity of INO-4500, a Synthetic DNA-based Vaccine against Lassa Virus (LASV), in a Phase 1b Clinical Trial in Healthy Ghanaian Adults
in Vaccines and Molecular Therapeutics
- 163 views